
Sign up to save your podcasts
Or


Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making.
CME information and select publications here.

140 Listeners

318 Listeners

499 Listeners

66 Listeners

32 Listeners

75 Listeners

14 Listeners

17 Listeners

13 Listeners

0 Listeners

118 Listeners

58 Listeners

3,349 Listeners

198 Listeners

43 Listeners

22 Listeners

363 Listeners

190 Listeners

41 Listeners

0 Listeners